true value of AMR101 is not due to it's TG lowering effects, (although that's a good billion or two )but in it's potential to reduce CV risk...and you will realize it soon.
it reduced several key emerging markers for residual CV risk
LPA2, APO-B, CRP
hope you have read about the anti-thrombotic, anti-platelet and anti-inflammatory effects of AMR101
Hope you have read about AMR101's effect on Carotid intimal medial thickening , test for atherosclerotic disease.
hope you saw in JELIS:
Primary Prevention - major coronary events - RR 19% P=0.011
Secondary Prevention -- major coronary events -RR 23% P=0.017
Prior MI 27% P=0.033
Prior Stroke 20% P=0.047
Prior MI or Intervention 41% P=0.008
Sub-group with Atherogenic Dyslipidemia (>150mg/dl and HDL < 40 mg/dl) 53% P=0.043
jelis cohort was very low heart risk
"Low Heart Risk Japanese population
Total cholesterol, mean (SD), mg/dl 270
LDL-cholesterol, mean (SD), mg/dl 178
HDL-cholesterol, mean (SD), mg/dl 55
Triglyceride, median (IQR), mg/dl 163"
g
Yes I will sell much north of 30$ after August so I pay 15% to you and my other passive partners in america. Thank you
Market Data 
Markets 
AI
